Skip to Content
Merck
All Photos(1)

Documents

SML3639

Sigma-Aldrich

CU-T12-9

≥98% (HPLC)

Synonym(s):

CU-T 12-9, N-Methyl-4-nitro-2-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)aniline

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C17H13F3N4O2
CAS Number:
Molecular Weight:
362.31
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77

Quality Level

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

Biochem/physiol Actions

CU-T12-9 is a potent activator of toll-like receptor signaling, selective for TLR1 and TLR2. CU-T12-9 binds selectively to toll-like receptors TLR1 and TLR2, facilitating the TLR1/2 heterodimeric complex formation and activating downstream signaling of NF-κB.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tomoya Muto et al.
Cell stem cell, 29(2), 298-314 (2022-01-20)
Clonal hematopoiesis (CH) is an aging-associated condition characterized by the clonal outgrowth of pre-leukemic cells that acquire specific mutations. Although individuals with CH are healthy, they are at an increased risk of developing myeloid malignancies, suggesting that additional alterations are
Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization
International Journal of Molecular Sciences, 23(10), 5478-5478 (2022)
Kui Cheng et al.
Science advances, 1(3) (2015-06-24)
Toll-like receptor (TLR) agonists activate both the innate and the adaptive immune systems. These TLR agonists have been exploited as potent vaccine adjuvants and antitumor agents. We describe the identification and characterization of a small molecule, N-methyl-4-nitro-2-(4-(4-(trifluoromethyl)phenyl)-1 H-imidazol-1-yl)aniline (CU-T12-9), that

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service